Publication | Closed Access

Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm

Breast OncologyNeoadjuvant ChemotherapyMedicineMachine Learning AlgorithmBrain MetastasisCancer RegistrationBreast CancerCancer TreatmentOncologyRadiation OncologyRadiologyHealth Sciences